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Abstract: Long-wavelength identification of microcalcifications in breast cancer tissue is 
demonstrated using a novel upconversion raster scanning microscope. The system consists of 
quantum cascade lasers (QCL) for illumination and an upconversion system for efficient, 
high-speed detection using a silicon detector. Absorbance spectra and images of regions of 
ductal carcinoma in situ (DCIS) from the breast have been acquired using both upconversion 
and Fourier-transform infrared (FTIR) systems. The spectral images are compared and good 
agreement is found between the upconversion and the FTIR systems. 
© 2018 Optical Society of America under the terms of the OSA Open Access Publishing Agreement 
1. Introduction
Breast cancer is the second most common cause of cancer death among women after lung 
cancer in the United States in 2018 [1]. To improve the prognosis for these patients, early and 
accurate diagnosis is necessary. Microcalcifications, which are abnormal deposits of calcium 
in the mammary gland, are a potential early marker for breast cancer [2]. They are classified 
according to their spatial distribution in the breast as well as their biochemical composition. 
In fact, two types of calcifications are observed in the breast: type I consisting of calcium 
oxalate mainly found in benign lesions and type II composed of calcium hydroxyapatite 
(Hap) involved in proliferative lesions and invasive cancer. Hap crystals Ca10(PO4)6(OH)2 
often include substituted ions of carbonate (CO32-), replacing either hydroxyl (OH-) or 
phosphate (PO43-) ions. The current method to detect these calcifications is based on X-ray 
mammography. But, unfortunately, this technique cannot discriminate between 
microcalcifications from benign and malignant lesions [2]. In contrast to mammography, 
vibrational spectroscopic imaging techniques can reveal the structural and molecular 
information from biological samples allowing for label-free characterization and diagnosis of 
human tissue [3]. Moreover, different studies suggest that vibrational spectroscopy could be 
used to discriminate the degree of the pathology in breast cancer based on their carbonate 
level [4]. 
The combination of microscopy and mid-infrared or Raman spectroscopy have progressed 
over the past decades and have become sensitive tools providing chemical information as well 
as structural details without exogenous staining of the samples [4]. Vibrational spectroscopic 
imaging can provide label free imaging or mapping of tissue sections to provide a spatial 
distribution of molecular compositions of cells and tissues, without recourse to stains. When 
mid-IR absorption spectra [5] or Raman inelastic scattering spectra are measured [6], at each 
microscopic pixel in the image, an exquisite data set can be acquired and interrogated for 
subtle changes associated with diseases. Raman and IR hyperspectral imaging are 
complimentary approaches and have been demonstrated to be able to discriminate numerous 
diseases based on spectral imaging of molecular changes associated with early and late 
diseases in various organs [7–10]. 
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Raman spectroscopy was first demonstrated by Haka et al. for analysis of chemical 
composition of microcalcifications in the different lesions of the breast [11]. Raman 
spectroscopic imaging can provide complimentary vibrational molecular spectral information 
on tissue samples, with less sample preparation needed than IR. However, Raman is a slower 
method, due to the low scattering cross-section of biomolecules. In order to increase Raman 
signal, coherent Raman scattering (CRS) techniques have been developed [12]. It has been 
demonstrated that the coherent anti-Stokes Raman scattering (CARS) and stimulated Raman 
scattering (SRS), can provide cellular and chemical compositions from tissues, such as from 
calcified cartilage [13]. CRS techniques are able to provide fast label-free imaging 
acquisition. Raman and CRS spectroscopy have many advantages such as high speed, high 
resolution and no water contribution, but auto-fluorescence from the biological sample is the 
most important challenge. Further translation of these technologies is expected to deliver 
numerous tools for use on ex vivo fluids/cells/tissues for point of care analysis of pathology or 
in vivo clinical applications. 
Fourier-Transform Infrared (FTIR) imaging is reasonably rapid (tens of minutes per 
spectral image) and is recognized as a highly effective and reliable method of providing 
spectral analysis of biological tissue samples [14]. However, FTIR is currently too slow for 
real-time imaging for the delivery of rapid hyperspectral pathology. In recent years, discrete 
frequency IR microscopes with tunable mid-IR laser sources, such as quantum cascade lasers, 
optical parametric oscillators or filtered supercontinuum light sources, enabling label-free 
classification of cancerous tissue have been demonstrated [15–20]. By tuning to a molecular 
absorbance wavelength of interest, real-time molecular imaging can be utilized for immediate 
unstained tissue analysis. Furthermore, for advanced spectral predication of disease, the 
Bhargava group has shown that using a confocal Agilent microscope with a QCL source 
coupled to a Mercury Cadmium Telluride (MCT) detector it was possible to screen 
automatically breast tissue biopsies (1 mm diameter) in ~1 hour, in High Definition [21]. 
To date all the above IR imaging techniques have relied upon detectors sensitive to mid-
IR photons, i.e. Mercury Cadmium Telluride Focal Plane Array (MCT-FPA) or 
microbolometer, for long-wavelength infrared (LWIR) detection. However, these detectors 
have a signal-to-noise ratio several orders of magnitude lower than that of silicon detectors. 
This is mainly due to the unavoidable dark noise originating from the finite temperature of the 
detector. Cooling is therefore required to optimize the performance of traditional LWIR 
detectors. Another issue is the response time of most direct LWIR detectors being much 
slower than their silicon counterpart, resulting in either low signal-to-noise ratio or long 
acquisition time for direct LWIR detection [22]. 
Frequency upconversion is an alternative approach to direct detection of infrared radiation 
[23–25]. Converting long-wavelength infrared emission into the visible/near infrared range 
via nonlinear frequency conversion allows for the use of silicon detectors. Moreover, silicon 
detectors are low noise, fast, sensitive, and cost efficient compared to their mid-infrared 
counterparts. It has been demonstrated, that it is possible to detect phosphate and carbonate 
bands in the breast cancer microcalcifications using upconversion detection [26]. There, a 
silicon power meter was used to acquire the upconverted signals. Due to the limited response 
time of the detector, the X-Y translation stage moved to each spatial position and then waited 
for the detector to complete the measurement before moving to the next position. Thus, the 
acquisition time was approx. 20 minutes per image (the area of 1 x 1 mm2, 20 μm step size). 
In this study, we demonstrate an upconversion raster scanning microscope that allows for 
the characterization of the histology and chemical composition of breast cancer 
microcalcifications in the LWIR spectral regime. Acquisition times per wavelength of approx. 
25 seconds are demonstrated for a scanned area of 1 x 1 mm2. The histological structure and 
molecular information of ex vivo breast cancer microcalcifications is analyzed using the 
upconversion raster scanning microscopy system, showing nice agreement with a Micro-
FTIR system. 
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2. Materials and methods 
2.1 Breast cancer sample 
The ex vivo breast cancer biopsy with microcalcifications, obtained with ethical approval 
from Gloucestershire Royal Hospitals NHS Foundation Trust, was from a patient who had 
undergone a biopsy for mammographically suspicious breast lesions and it was selected from 
the histopathological report. The biopsy was embedded in paraffin and two 3 µm-thick 
adjacent sections were cut from the biopsy sample and analyzed. One section without staining 
was mounted onto a 0.5 mm-thick Barium fluoride (BaF2) disc and analyzed using Micro-
FTIR and the upconversion microscopy systems. The tissue section was required to be thin to 
enable sufficient IR light to penetrate the highly absorbing mineralized tissue. The other 
section with Hematoxylin and Eosin (H&E) staining was used for histological analysis as the 
gold standard reference. 
2.2 Instrumentation – micro-FTIR system 
FTIR imaging of the unstained breast cancer biopsy section was performed with an Agilent 
620 FTIR microscope, equipped with a 15x Cassegrain objective and a 128 x 128 pixel liquid 
nitrogen-cooled MCT-FPA detector, and a globar source. This was coupled with an Agilent 
670 FTIR spectrometer. Infrared spectra ranging from 3900 to 800 cm−1 were recorded with a 
spectral resolution of 4 cm−1 and a pixel size of 5.5 µm. Each spectrum was obtained by 
averaging 64 scans and ratioed with a background spectrum averaging 256 scans. The FTIR 
spectra were collected using Agilent ResolutionPro software. 
2.3 Instrumentation – upconversion microscopy system 
The unstained breast biopsy section, containing microcalcifications, was also analyzed using 
a home-built upconversion raster scanning microscope. The setup is illustrated in Fig. 1(a). A 
quantum cascade laser (Mini-QCL 100, BLOCK engineering) was used as a widely tunable, 
narrow linewidth, LWIR source tunable from 9.43 to 12 µm, delivering 50 ns pulses with a 
temporal separation of 1 µs. The LWIR beam was coupled to a scanning microscope allowing 
for mechanically stable raster scanning of the biopsy sample. The sample was placed between 
two ZnSe lenses, mounted on Z-axis translation mounts (f1 = f2 = 20 mm) giving a LWIR 
beam waist (radius) of approx. 28 µm in the sample plane (measured using knife edge 
scanning with the translation stage). Two lenses (f3 = 50 mm and f4 = 150 mm) were used to 
focus the transmitted LWIR and the near infrared (NIR) mixing beams, respectively, into a 
nonlinear crystal via a beam combiner. In the nonlinear crystal, the LWIR beam is mixed with 
the mixing beam for sum frequency generation. An 8 W diode laser was used to pump a 
Nd:YVO4 laser generating the 1064 nm single-pass mixing field, giving a maximum output 
power of 3W in continuous-wave operation. The sum frequency generation (SFG) was 
realized in a 5 x 5 x 10 mm3 AgGaS2 crystal. The AgGaS2 crystal was cut at θ = 43.3° (φ = 0) 
for collinear type II phase-matching (eLWIR + oNIR → eUp). The AgGaS2 crystal was mounted 
on a piezo controlled rotation stage (ECR3030, Attocube) for angle tuned birefringent phase-
matching, converting the LWIR signal to the 950 to 980 nm range. For further details see ref 
[25]. Three short-pass filters (FESH1000, Thorlabs) and a long-pass filter (FELH900, 
Thorlabs) were used in line before the upconverted signals were detected with a silicon 
detector (PDA 100A, Thorlabs). 
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Fig. 1. (a). Schematic layout of experimental setup for upconversion raster scanning 
microscope. (b) Raster scanning scheme. 
The X-Y translation stage scans in two dimensions using raster scanning, as shown in Fig. 
1(b). The stage moves in the X-direction (fast axis) with a constant velocity of 5 mm/s and in 
the Y-axis with a step size of 10 μm (between the strips in X-axis). The X-Y translation stage 
has angular encoders on the axis spindles providing two quadrature electric signals to allow 
for tracking of the position. The X-Y positions and the analogue signal from the silicon 
detector were processed by the Data Acquisition module (DAQ National Instruments NI-
6251). The sampling rate of the DAQ module is set to 100 kHz taking samples 
simultaneously from the Analog to Digital Converter (ADC) and the position decoders. The 
upconverted signals from the silicon detector was low-pass filtered with a 1 kHz analog 
passive filter, giving a response, which preserves the signal representing the features in the 
target, but rejects unwanted high-frequency components (essentially working as an anti-
aliasing filter). Because the sampling rate is 500 times the bandwidth of the signal of interest, 
there is a wide frequency range for this analogue filter to operate in and it can be made as a 
simple first-order passive filter. To remove all signals outside the band of interest the digital 
data stream was subsequently digitally filtered by a Finite Impulse Response (FIR) low-pass 
filter (Filter Express VI, LabVIEW) with the low-pass frequency at 200 Hz (at 0.1 dB). This 
filter has an impulse response with a full-width half maximum of approx. 0.6 ms, which 
corresponds to a spatial translation of 3 μm at the scanning speed of 5 mm/s. As this width is 
much smaller than the illumination beam diameter of 56 µm, the filter only slightly 
deteriorates the combined spatial resolution. The filtered signals were then binned according 
to the corresponding position (X,Y) and accommodated into an image array with a pixel size 
of 10 μm x 10 μm. Finally, the image is resampled into an expanded array with a pixel size of 
1.8 μm x 1.8 μm, cropping the field of view to remove regions with non-constant scanning 
speed at the end of each X-scan (where the scanning direction is changed). 
3. Results and discussion 
3.1 Illumination area of the sample 
The LWIR illumination beam was measured in the plane of the biological sample, using the 
knife-edge method. Knifes were placed on the X-Y translation stage, and scanned across the 
LWIR beam in both the X- and Y-directions. The transmitted LWIR signal was upconverted 
(a) (b) 
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and detected with the silicon detector. The measured beam size in the object plane using this 
approach was found to be Gaussian with an approx. beam diameter of 56 µm. 
3.2 Air Force 1951 resolution target 
The performance of the upconversion microscopy is demonstrated imaging a USAF 1951 
resolution target. The resolution target was placed on the X-Y translation stage for raster 
scanning and illuminated by the LWIR beam at 970 cm−1. The transmitted light was mixed 
with the 1064 nm laser for sum frequency generation, giving an upconversion signals at 964 
nm. The upconverted signal was detected with the silicon detector. Figure 2(a) and (b) show 
upconversion images of the resolution target group 2 and 3, respectively. The intensity 
profiles across the horizontal set of bars (red/blue dashed lines) are illustrated in Fig. 2(c) and 
(d), respectively. The target features are well resolved corresponding to a resolution higher 
than 35 μm (Group 3, element 6). The decreasing intensity in Fig. 2(d) for the finer structures 
reflects the narrow aperture compared to the larger illumination beam, however, the 
modulation between the lines clearly shows that the lines are spatially resolved. 
 
Fig. 2. USAF 1951 optical resolution target (a) group 2, element 2-6 (b) group 3, element 1-6 
imaged with the upconversion raster scanning microscope in transmission. Images displayed 
were obtained at 970 cm−1 (10.31 μm) corresponding to the upconverted signal at 964 nm. 
Intensity profiles across the horizontal set of bars (red/blue dashed lines) were plotted in (c) 
and (d) respectively. 
3.3 Microcalcifications from an ex vivo sample of breast DCIS 
The study presented here aims to develop a diagnostic tool, to analyze breast cancer tissue 
biopsies in the 1060 to 830 cm−1 spectral range, retrieving spectral information related to the 
phosphate and carbonate bands. In this region, these bands are not overlaid by paraffin signal. 
Discrete wavelength tuning is a time efficient approach to acquire the spectral signatures of 
the tissue sample under investigation. 
Figure 3(a) shows a histological section of DCIS with H&E staining and transmission 
microscope examination of the tissue. The adjacent unstained section was evaluated using 
micro-FTIR imaging, see Fig. 3(b), and the upconversion raster scanning microscopy 
systems, see Fig. 3(c). The FTIR and upconverted images were measured at the phosphate 
peak at 1020 cm−1. The LWIR signal transmitted through the sample was upconverted from 
1020 cm−1 into the near infrared (958.8 nm) and detected using the silicon detector. The area 
(approx. 0.5 mm2), corresponding to microcalcification area in the biopsy sample, was 
marked with the black squares in Fig. 3. The acquisition time of the FTIR image, with area of 
0.5 mm2 as a single image tile of FTIR averaged by 64 scans in the spectral range of 3900-
800 cm−1 at the interval of 4 cm−1, was approx. 5 minutes, and a monochromatic image with 
the same area can be measured in 30 seconds using the upconversion system. The actual 
acquisition time using the upconversion system mainly depends on the number of 
wavelengths needed to identify the microcalcifications and the desired image size. The 
acquisition time is currently limited by the scan speed of the X-Y translation stage, but higher 
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scan speed will reduce the signal-to-noise ratio as a result of reduced integration time of the 
individual spatially resolvable element. 
Comparing the FTIR image and upconversion image in Fig. 3(b) and (c), the absorbance 
measurements generally show good agreement. However, in the center of the calcified 
regions, the absorbance is significantly higher in the upconversion image compared to the 
FTIR image, this is believed to be a result of the coherent illumination used in the 
upconversion system [27]. 
 
Fig. 3. Histological section of DCIS breast cancer microcalcifications with H&E staining 
imaged with the transmission microscope. The area marked with the black squares is 
approx.0.5 mm2. (b) FTIR absorbance image with the size of approx.1.4 mm x 1.7 mm 
referring to phosphate peak at 1020 cm−1 (c) Upconversion absorbance image with the size of 
approx.1.3 mm x 1.2 mm obtained at 1020 cm−1 corresponding to the upconverted signal at 
958.8 nm. 
Only few discrete wavelengths are required to identify the microcalcifications for the 
phosphate and carbonate bands at 1020 cm−1 and 875 cm−1. In order to map out the spectral 
features of the microcalcifications and compare the spectra, multispectral imaging was 
performed with the upconversion system and compared to spectra obtained with the Micro-
FTIR system. Figure 4(a) shows the multispectral images obtained with upconverted at 1040, 
1032, 1020, 1005, 970, 962, 950, 910, 881, 875, 860, and 850 cm−1. The wavelength of 
interest was set for the QCL with an illumination bandwidth of ∼1 cm−1 and the nonlinear 
crystal was rotated for optimal conversion efficiency for each wavelength [25]. Reference 
measurements on an empty area of the BaF2 sample mount were performed at each 
wavelength for calculation of the sample absorbance. Figure 4(b) shows absorbance spectra 
obtained using the Micro-FTIR (solid lines) and upconversion system (dots) for a region of 
comedo DCIS (containing a microcalcification), and Fig. 4(c) shows the corresponding 
absorbance spectra measured in an area of non-cancerous connective tissue (not containing 
calcifications). The FTIR system becomes noisy in the LWIR regime (900 to 800 cm−1), 
resulting in spectral artifacts. The upconverted absorbance was retrieved from the series of 
images illustrated in Fig. 4(a) and extracted from the area where the phosphate band is highly 
absorbing (pink arrow) and from surrounding tissue (orange arrow). A significant decrease in 
the signal (increased absorbance) is seen at the phosphate absorption band in the 
microcalcification area (pink arrow) compared to the surrounding. The carbonate peak is also 
seen at the signal around 875 cm−1. The upconverted spectrum shows a good agreement with 
FTIR spectrum. Generally, upconversion detection gives a superior SNR at low signal levels 
(high absorbance’s due to the very low dark noise in the Si detector) [28,29]. This is highly 
pertinent to the highly absorbing breast calcifications, and may allow for the use of thicker 
samples. 
                                                                              Vol. 9, No. 10 | 1 Oct 2018 | BIOMEDICAL OPTICS EXPRESS 4984 
 Fig. 4. (a) Multispectral upconversion images of the DCIS breast microcalcifications obtained 
at 1040, 1032, 1020, 1005, 970, 962, 950, 910, 881, 875, 860, and 850 cm−1 corresponding to 
the upconverted signals in the range of 958 to 976 nm. Spectra measured using Micro-FTIR 
(Agilent) and upconversion systems from (b) microcalcification (pink arrow) and (c) 
surrounding tissue (orange arrow) in breast sample. It is noticeable that absorbance obtained in 
microcalcification (b) and surrounding tissue (c) are in a different scale. 
4. Conclusion 
We demonstrate that breast cancer tissues can be analyzed using the upconversion raster 
scanning microscopy system without the use of exogenous staining. The use of upconversion 
can enable fast image acquisition compared to FTIR microscopic imaging, through the use 
silicon detectors, potentially improving speed and the signal-to noise ratio, even at low cost 
and without the need for cryogenic cooling. The presented result shows excellent agreement 
between upconversion raster scanning microscopy and Micro-FTIR imaging, in terms of 
spatial distribution and spectral features of breast microcalcifications. Discrete wavelength 
turning can reduce the acquisition time, depending on the number of wavelengths needed for 
diagnoses. This new approach has the potential to measure fresh tissue samples, without the 
need for exogenous staining, and with much improved speed over Micro-FTIR imaging. 
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